No, it's easy now that I have the code, I'll run it tomorrow and put up the results. I haven't looked too closely at the GVHD trial results before, so that was an honest question and happy to re-run it for 25 and 30%, hope it didn't come across dismissive!
I think it's a possible scenario that the COVID trial has a higher treated group mortality than the EUA had, and something I have admittedly neglected in most of these analyses, so you've got a great point that it would be good to check it for other treated group mortality rates.
Overwhelming efficacy - the stats required, page-375
-
- There are more pages in this discussion • 202 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.000(0.00%) |
Mkt cap ! $1.347B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4480 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 4727 | 5 |
View Market Depth
| Last trade - 10.01am 17/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable